Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3.
about
Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.Correlating EGFR expression with receptor-binding properties and internalization of 64Cu-DOTA-cetuximab in 5 cervical cancer cell linesAssessing tumor hypoxia by positron emission tomography with Cu-ATSMCharacterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution.Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK.Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.Matching chelators to radiometals for radiopharmaceuticals.Radiolabeling strategies for tumor-targeting proteinaceous drugs.Molecular imaging with copper-64 in the drug discovery and development arena.Site-specific conjugation of bifunctional chelator BAT to mouse IgG1 Fab' fragment.Correction to: Characterization of the first fully human anti-TEM1 scFv in models of solid tumor imaging and immunotoxin-based therapy.Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers.Optimized preparation and preliminary evaluation of [64Cu]–DOTA–trastuzumab for targeting ErbB2/Neu expression
P2860
Q27339846-9D0C72E9-2515-48D3-B473-D88CF3EDC574Q34778496-4F5022D3-00B5-477F-9145-24DAE869C7FDQ35565683-E4D60DFE-15D2-408B-8F85-048FA3071419Q36216991-88C0AC15-8AC6-489F-BA79-2E2C04EED55AQ36870970-234EAF81-C19F-429B-8382-A4FA868DCECCQ37289392-32CF7A11-FE23-4BE8-A211-41C52E616B1AQ37478003-E18EC540-5FC4-4904-9828-58993514B10DQ37515337-B84E13B3-69A3-481C-ACBE-5D37D8013784Q38156660-D9BE2730-990A-481F-9A2E-E04C58B17A6AQ38189541-9FC71294-9837-4C9A-9FB0-F5A07B7211D7Q38448424-78219E02-A8FB-4263-9026-999999AA88D5Q40330017-90DB22BF-6D8D-48B8-A8F2-92DFB22C0485Q47193015-6BD14853-7DF4-4AB6-8C23-2828EBA2FF8FQ48136353-6A40B14D-E4C1-44AC-8123-533359FC7441Q57567743-8351F442-DCC4-4BAA-861A-6A75D1BA7BA4
P2860
Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Conjugation of monoclonal anti ...... ETA-1A3 with 64Cu-BAT-2IT-1A3.
@en
Conjugation of monoclonal anti ...... ETA-1A3 with 64Cu-BAT-2IT-1A3.
@nl
type
label
Conjugation of monoclonal anti ...... ETA-1A3 with 64Cu-BAT-2IT-1A3.
@en
Conjugation of monoclonal anti ...... ETA-1A3 with 64Cu-BAT-2IT-1A3.
@nl
prefLabel
Conjugation of monoclonal anti ...... ETA-1A3 with 64Cu-BAT-2IT-1A3.
@en
Conjugation of monoclonal anti ...... ETA-1A3 with 64Cu-BAT-2IT-1A3.
@nl
P2093
P1476
Conjugation of monoclonal anti ...... TETA-1A3 with 64Cu-BAT-2IT-1A3
@en
P2093
P304
P356
10.1089/10849780152752083
P577
2001-12-01T00:00:00Z